Autoimmune disease influence on polycystic ovary syndrome: Insights from Mendelian randomization and multi-omics analysis
Advances in Clinical and Experimental Medicine · 2026
DOI: 10.17219/acem/214667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2026. Verfasst von Jing Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Third Clinical Medical College, Nanjing University of Chinese Medicine, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Mendelian Randomization Analysis, Autoimmune Diseases. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Clinical Medical College, Nanjing University of Chinese Medicine, China.
- Department of Obstetrics and Gynecology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, China.
- Department of Obstetrics and Gynecology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Zitieren
APA
Yu, J., Chen, S., Chen, Y., Chu, T., Zhou, K., & Wang, P. (2026). Autoimmune disease influence on polycystic ovary syndrome: Insights from Mendelian randomization and multi-omics analysis. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/214667
Vancouver
Yu J, Chen S, Chen Y, Chu T, Zhou K, Wang P. Autoimmune disease influence on polycystic ovary syndrome: Insights from Mendelian randomization and multi-omics analysis. Advances in Clinical and Experimental Medicine. 2026. doi:10.17219/acem/214667
BibTeX
@article{Yu2026,
author = {Yu, Jing and Chen, Si and Chen, Yue and Chu, Tong and Zhou, Keda and Wang, Peijuan},
title = {Autoimmune disease influence on polycystic ovary syndrome: Insights from Mendelian randomization and multi-omics analysis},
journal = {Advances in Clinical and Experimental Medicine},
year = {2026},
doi = {10.17219/acem/214667}
}
EUVIMED